세계의 크로마토그래피 수지 시장(-2030년) : 유형별(천연, 합성, 무기 매체), 방법별(이온 교환(양이온, 음이온), 어피니티(소수성 상호작용, 혼합 모드)), 용도별(의약품, 바이오테크놀러지), 지역별

The global chromatography resin market size is projected to reach USD 4.94 billion by 2030 from USD 3.02 billion in 2024, at a CAGR of 8.6% between 2025 to 2030.

Chromatography resins are utilized in sensitive processes like cleaning drugs, food additives, environmental, and industrial chemicals. They are used to give separation and isolation of valuable components of a complex mixture to guarantee product purity, safety, and compliance. These resins enhance the efficiency of the separation processes, as well as reduce the processing time, and minimize the use of harsh chemicals involved in the separation processes.

Chromatography resins are designed in such a way that they can be reused, exerted to different pressures and certain pH levels, and still remain effective. Besides, more industries are turning to use these resins as interest and demand in safer and high-quality biologics increases, and the enforcement of purity and contaminants involved with pharmaceuticals, food, and environmental testing. Advances in resin chemistry and functional ligands are increasing the selectivity and stability of resins, and this is increasing market penetration. With the growing separation and purification requirements being experienced in different fields, chromatography resins are of much importance in the attainment of high-performance results. Chromatography resins are now being demanded more because of the fast industrialization and increasing food processing and online retail activities across the globe.

"Natural polymers type segment is projected to register the second-highest CAGR of chromatography resins market, in terms of value, during the forecast period."

During the forecast period, natural polymers are estimated to have the highest CAGR in terms of value, in the chromatography resin market due to their biocompatibility, high porosity, and the prevalence of their use in bioseparation processes. Agarose, cellulose, and dextran are ideal materials used in purification of delicate biomolecules such as proteins, enzymes, and antibodies, particularly in the biopharmaceutical industry. These polymers present a high hydrophilicity and low nonspecific binding, producing separation with greater purity and yield. With the increasing need to have monoclonal antibodies, gene therapies, and other biologics, there is a massive increase in the application of natural polymer-based resins. Moreover, they have a renewable nature and eco-friendly reputation, which could also help increase the rate of industry interest in being more sustainable and implementing green approaches to manufacturing. Continued technology development in the areas of natural polymer modification and crosslinking are also increasing their mechanical strength and applicability, and further opening them up to wider industry applicability, and further increasing their market expansion.

"Pharmaceutical & biotechnology segment is projected to register the highest CAGR in the chromatography market, in terms of value, in 2030."

The pharmaceuticals and biotechnology application segment is estimated to register the highest CAGR in the chromatography resin market in the forecast period because of the all-inclusive increase in the demand for biologics, monoclonal antibodies, vaccines, and gene therapies. Chromatographic resins play an important role in the purification of those complex biomolecules in downstream processing, where purity and product integrity are paramount when it comes to chromatography resins. The booming number of cases of chronic illnesses, the growing cost of healthcare services, and the increase in personalized medicine have expedited the use of advanced drug development and production processes, of which chromatography plays a pivotal role. The increase in the pipeline of biosimilars and the quality and consistency in drug manufacturing emphasized by regulatory authorities are also driving the demand. Due to the rise in R&D and development activities worldwide by biotechnology firms and pharmaceutical companies, more biomanufacturing capacities are being established in various parts of the world, especially in emerging markets. These factors, along with ongoing innovation in resin chemistry and purification technologies, are likely to support strong growth in this application sector.

"Europe is projected to register the third-highest CAGR during the forecast period in the chromatography resin market, in terms of value."

Europe is expected to record the third-highest CAGR in the chromatography resin market during the forecast period, due to its mature but continuously developing pharmaceutical and biotechnology industry. Some of the worldwide biopharma corporations, contract research organizations (CROs), and research universities extensively apply chromatography procedures to develop drugs, manage quality, and conduct clinical research. Government funding of innovation and research & development is encouraging growth in the chromatography resin market, and because of this, there is an increasing level of investment taking place in biologics and also in biosimilars. Also, on the one hand, high regulatory requirements imposed by the European Medicines Agency (EMA) promote the necessity of a high-performance purification process, and chromatography resins cannot be avoided. Despite a rather moderate rate of growth in comparison with the one observed in emerging markets in Asia Pacific, the constant improvement of life sciences, environmental and food safety testing, etc., still maintains the consistent demand. The high rates of quality, safety, and environmental friendliness make Europe a major contributor to the growth of the worldwide chromatography resin market.

• By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20%
• By Designation: Directors - 50%, Managers - 30%, and Others - 20%
• By Region: North America - 40%, Europe - 35%, Asia Pacific - 20%, Rest of World - 5%

The key players profiled in the report include Bio-Rad Laboratories, Inc. (US), Merck KgaA (Germany), Danaher Corporation (US), Tosoh Corporation (Japan), Sartorius Stedim Biotech S.A. (France), Bio-Works Technologies AB (Sweden), Avantor, Inc. (US), Purolite (US), Repligen Corporation (US), Mitsubishi Chemical Group Corporation (Japan), and Thermo Fisher Scientific Inc. (US), among others.

Research Coverage

This report segments the market for chromatography resin based on type, technique, application, and region, and provides estimations in terms of value (USD million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies associated with the market for chromatography resin.

Reasons to Buy this Report

This research report is focused on various levels of analysis - industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the chromatography resin market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on chromatography resin offered by top players in the global market
• Analysis of key drivers (increasing pharmaceutical & biotech R&D activities, rising demand for therapeutic antibodies, mounting demand for biosimilars, rising concern for food safety, and growing use of liquid chromatography-mass spectrometry in analytics), restraints (Absence of suitable skilled professionals), opportunities (increase in contract manufacturing organizations and CROs in pharmaceutical industry, increasing demand for disposable pre-packed columns, mounting demand for chromatography in drug development and omics research, rising use of chromatography in proteomics), and challenges (accessible alternative technologies to chromatography) influencing the growth of chromatography resin market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the chromatography resin market
• Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for chromatography resin across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global chromatography resin market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the chromatography resin market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 UNITS CONSIDERED
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary interviews: Demand side and supply side
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
  • 2.4.1 SUPPLY SIDE
  • 2.4.2 DEMAND SIDE
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CHROMATOGRAPHY RESINS MARKET
• 4.2 CHROMATOGRAPHY RESINS MARKET, BY REGION
• 4.3 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE AND COUNTRY
• 4.4 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE
• 4.5 REGIONAL ANALYSIS: CHROMATOGRAPHY RESINS MARKET, B TECHNIQUE
• 4.6 CHROMATOGRAPHY RESINS MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing pharmaceutical and biopharmaceutical R&D activities
    • 5.2.1.2 Increasing demand for therapeutic antibodies
    • 5.2.1.3 Increasing demand for biosimilars
    • 5.2.1.4 Rising food safety concerns
    • 5.2.1.5 Increasing use of liquid chromatography-mass spectrometry in analytics and research
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Lack of skilled professionals
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rise of CMOs and CROs in pharmaceutical industry
    • 5.2.3.2 Growing demand for disposable pre-packed columns
    • 5.2.3.3 Growing demand for chromatography in drug development and omics research
    • 5.2.3.4 Growing use of chromatography in proteomics
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Presence of alternative technologies to chromatography
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF SUBSTITUTES
  • 5.3.2 BARGAINING POWER OF SUPPLIERS
  • 5.3.3 BARGAINING POWER OF BUYERS
  • 5.3.4 THREAT OF NEW ENTRANTS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.4.2 BUYING CRITERIA
• 5.5 MACROECONOMIC INDICATORS
  • 5.5.1 GDP TRENDS AND FORECAST FOR MAJOR ECONOMIES

6 INDUSTRY TRENDS

• 6.1 SUPPLY CHAIN ANALYSIS
• 6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 6.3 ECOSYSTEM ANALYSIS
• 6.4 TRADE ANALYSIS
  • 6.4.1 IMPORT SCENARIO (HS CODE 391400)
  • 6.4.2 EXPORT SCENARIO (HS CODE 391400)
• 6.5 PRICING ANALYSIS
  • 6.5.1 AVERAGE SELLING PRICE OF CHROMATOGRAPHY RESINS OFFERED BY KEY PLAYERS, BY TECHNIQUE, 2024
  • 6.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2030
• 6.6 TECHNOLOGY ANALYSIS
  • 6.6.1 KEY TECHNOLOGIES
    • 6.6.1.1 Jetting
    • 6.6.1.2 Microfluidics
  • 6.6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.6.2.1 Surface modification via click chemistry
    • 6.6.2.2 3D printing of chromatographic structures
• 6.7 CASE STUDY ANALYSIS
  • 6.7.1 BIO-WORKS TECHNOLOGIES - WORKBEADS AFFIMAB FOR MONOCLONAL ANTIBODY PURIFICATION
  • 6.7.2 CYTIVA - PROTEIN SELECT RESIN FOR TAG-BASED PROTEIN PURIFICATION
  • 6.7.3 REPLIGEN - COVID-19 SPIKE PROTEIN AFFINITY RESIN FOR VACCINE DEVELOPMENT
• 6.8 REGULATORY LANDSCAPE
  • 6.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.8.2 REGULATIONS
    • 6.8.2.1 REACH Regulations (EC) No. 1907/2006 - European Union (ECHA)
    • 6.8.2.2 USP <665>, <661.1>, and <661.2> - United States Pharmacopeia
    • 6.8.2.3 WHO GMP Guidelines for Biological Products
    • 6.8.2.4 ICH Q7 - GMP for Active Pharmaceutical Ingredients
    • 6.8.2.5 21 CFR Part 210 & 211 - US (FDA)
    • 6.8.2.6 EudraLex Volume 4 - EU GMP Guidelines (EMA)
• 6.9 KEY CONFERENCES AND EVENTS, 2025-2026
• 6.10 INVESTMENT AND FUNDING SCENARIO
• 6.11 PATENT ANALYSIS
  • 6.11.1 APPROACH
  • 6.11.2 PATENT TYPES
  • 6.11.3 TOP APPLICANTS
  • 6.11.4 JURISDICTION ANALYSIS
• 6.12 IMPACT OF AI/GEN AI ON CHROMATOGRAPHY RESINS MARKET
• 6.13 IMPACT OF 2025 US TARIFF ON CHROMATOGRAPHY RESINS MARKET
  • 6.13.1 INTRODUCTION
  • 6.13.2 KEY TARIFF RATES
  • 6.13.3 PRICE IMPACT ANALYSIS
  • 6.13.4 IMPACT ON COUNTRY/REGION
    • 6.13.4.1 US
    • 6.13.4.2 Europe
    • 6.13.4.3 Asia Pacific
  • 6.13.5 IMPACT ON END-USE INDUSTRY
    • 6.13.5.1 Food & beverage industry
    • 6.13.5.2 Pharmaceutical & biotechnology industry

7 CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE

• 7.1 INTRODUCTION
• 7.2 ION EXCHANGE CHROMATOGRAPHY
  • 7.2.1 HIGH DEMAND IN BIOPHARMACEUTICAL PROCESSES TO DRIVE MARKET
  • 7.2.2 CATION EXCHANGE CHROMATOGRAPHY
  • 7.2.3 ANION EXCHANGE CHROMATOGRAPHY
• 7.3 AFFINITY CHROMATOGRAPHY
  • 7.3.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET
  • 7.3.2 BIOSPECIFIC LIGAND-BASED AFFINITY CHROMATOGRAPHY
    • 7.3.2.1 Protein A affinity
    • 7.3.2.2 Protein G affinity
    • 7.3.2.3 Protein L affinity
    • 7.3.2.4 Lectin affinity
    • 7.3.2.5 Others
  • 7.3.3 PSEUDO-BIOSPECIFIC LIGAND-BASED AFFINITY CHROMATOGRAPHY
    • 7.3.3.1 IMAC
    • 7.3.3.2 Dye-based ligands
    • 7.3.3.3 Others
• 7.4 SIZE-EXCLUSION CHROMATOGRAPHY
  • 7.4.1 WIDE APPLICATION IN LABORATORIES TO SUPPORT MARKET GROWTH
• 7.5 HYDROPHOBIC INTERACTION CHROMATOGRAPHY
  • 7.5.1 RISING DEMAND FOR BIOSIMILARS TO DRIVE DEMAND
• 7.6 MIXED-MODE CHROMATOGRAPHY
  • 7.6.1 BETTER DEGREE OF PURIFICATION THAN OTHER TECHNIQUES TO DRIVE MARKET
• 7.7 OTHER TECHNIQUES
  • 7.7.1 PARTITION CHROMATOGRAPHY
  • 7.7.2 ADSORPTION CHROMATOGRAPHY

8 CHROMATOGRAPHY RESINS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 PHARMACEUTICAL & BIOTECHNOLOGY
  • 8.2.1 INCREASED R&D EXPENDITURE OF BIOTECHNOLOGY COMPANIES TO DRIVE DEMAND
  • 8.2.2 PRODUCTION
  • 8.2.3 ACADEMICS & RESEARCH
• 8.3 FOOD & BEVERAGE
  • 8.3.1 STRINGENT REGULATIONS FOR FOOD SAFETY TO DRIVE MARKET
• 8.4 WATER & ENVIRONMENTAL ANALYSIS
  • 8.4.1 RISING DEMAND FOR SAFE WATER AND STRINGENT REGULATIONS TO DRIVE GROWTH
• 8.5 OTHER APPLICATIONS

9 CHROMATOGRAPHY RESINS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 ASIA PACIFIC
  • 9.2.1 CHINA
    • 9.2.1.1 Investments by companies in innovative drugs to drive market
  • 9.2.2 JAPAN
    • 9.2.2.1 Increasing demand for generic drugs and monoclonal antibody biosimilars to drive resin consumption
  • 9.2.3 SOUTH KOREA
    • 9.2.3.1 Government initiatives to boost production of biosimilars to drive market
  • 9.2.4 INDIA
    • 9.2.4.1 Growth of pharmaceutical & biotechnology industry to drive market
  • 9.2.5 AUSTRALIA
    • 9.2.5.1 Rising demand for monoclonal antibodies to drive market
  • 9.2.6 NEW ZEALAND
    • 9.2.6.1 Increasing demand for purification techniques in food industry to drive market
• 9.3 NORTH AMERICA
  • 9.3.1 US
    • 9.3.1.1 Increasing R&D investments in healthcare industry to drive demand
  • 9.3.2 CANADA
    • 9.3.2.1 Increased R&D activities in biopharmaceutical sector to support market growth
  • 9.3.3 MEXICO
    • 9.3.3.1 Initiatives to encourage biosimilars and biopharmaceutical research to drive demand
• 9.4 EUROPE
  • 9.4.1 GERMANY
    • 9.4.1.1 Increasing R&D investments by biotechnology companies to drive market
  • 9.4.2 FRANCE
    • 9.4.2.1 Increasing investments by pharmaceutical companies to drive market
  • 9.4.3 UK
    • 9.4.3.1 Top companies with therapeutic mAbs in different stages of R&D to drive market
  • 9.4.4 ITALY
    • 9.4.4.1 Established pharmaceutical industry to increase demand
  • 9.4.5 SPAIN
    • 9.4.5.1 Increasing R&D activities in pharmaceutical companies to drive market
  • 9.4.6 SCANDINAVIA
    • 9.4.6.1 Growing pharmaceutical industry to drive market
  • 9.4.7 AUSTRIA
    • 9.4.7.1 Increasing demand for monoclonal antibodies to drive market
  • 9.4.8 SWITZERLAND
    • 9.4.8.1 High investment in pharmaceutical research to have positive impact on market
• 9.5 MIDDLE EAST & AFRICA
  • 9.5.1 GCC COUNTRIES
    • 9.5.1.1 Saudi Arabia
      • 9.5.1.1.1 Growth in pharmaceutical industry to increase demand
    • 9.5.1.2 UAE
      • 9.5.1.2.1 Investments in R&D facilities for production of innovative biological and generic drugs to drive demand
• 9.6 SOUTH AMERICA
  • 9.6.1 BRAZIL
    • 9.6.1.1 Rising demand for low-cost biosimilars to drive demand

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 10.3 MARKET SHARE ANALYSIS
• 10.4 REVENUE ANALYSIS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 Technique footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.6.5.1 Detailed list of key startups/SMEs
    • 10.6.5.2 Competitive benchmarking of key startups/SMEs
• 10.7 BRAND/PRODUCT COMPARISON ANALYSIS
• 10.8 COMPANY VALUATION AND FINANCIAL METRICS
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 MAJOR PLAYERS
  • 11.1.1 BIO-RAD LABORATORIES, INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products/Solutions/Services offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 MERCK KGAA
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products/Solutions/Services offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Expansions
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 DANAHER CORPORATION
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products/Solutions/Services offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches
      • 11.1.3.3.2 Deals
      • 11.1.3.3.3 Expansions
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 TOSOH CORPORATION
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products/Solutions/Services offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches
      • 11.1.4.3.2 Deals
      • 11.1.4.3.3 Expansions
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 SARTORIUS STEDIM BIOTECH S.A.
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products/Solutions/Services offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches
      • 11.1.5.3.2 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 BIO-WORKS TECHNOLOGIES AB
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products/Solutions/Services offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches
      • 11.1.6.3.2 Deals
    • 11.1.6.4 MnM view
      • 11.1.6.4.1 Key strengths
      • 11.1.6.4.2 Strategic choices
      • 11.1.6.4.3 Weaknesses and competitive threats
  • 11.1.7 AVANTOR, INC.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products/Solutions/Services offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product launches
      • 11.1.7.3.2 Deals
      • 11.1.7.3.3 Expansions
    • 11.1.7.4 MnM view
      • 11.1.7.4.1 Key strengths
      • 11.1.7.4.2 Strategic choices
      • 11.1.7.4.3 Weaknesses and competitive threats
  • 11.1.8 MITSUBISHI CHEMICAL GROUP CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products/Solutions/Services offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches
      • 11.1.8.3.2 Expansions
  • 11.1.9 PUROLITE
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products/Solutions/Services offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches
      • 11.1.9.3.2 Deals
      • 11.1.9.3.3 Expansions
  • 11.1.10 REPLIGEN CORPORATION
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products/Solutions/Services offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product launches
      • 11.1.10.3.2 Deals
      • 11.1.10.3.3 Expansions
  • 11.1.11 THERMO FISHER SCIENTIFIC INC.
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products/Solutions/Services offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches
      • 11.1.11.3.2 Deals
      • 11.1.11.3.3 Expansions
• 11.2 OTHER PLAYERS
  • 11.2.1 SEPRAGEN CORPORATION
  • 11.2.2 STEROGENE BIOSEPARATIONS, INC.
  • 11.2.3 JACOBI GROUP
  • 11.2.4 CHEMRA GMBH
  • 11.2.5 SUNRESIN NEW MATERIALS CO. LTD.
  • 11.2.6 BIOTOOLOMICS LIMITED
  • 11.2.7 CUBE BIOTECH GMBH
  • 11.2.8 JSR LIFE SCIENCES, LLC
  • 11.2.9 NINGBO ZHENGGUANG RESIN CO., LTD.
  • 11.2.10 CONCISE SEPARATIONS
  • 11.2.11 GENSCRIPT BIOTECH CORPORATION
  • 11.2.12 EICHROM TECHNOLOGIES, LLC
  • 11.2.13 AGILENT TECHNOLOGIES, INC.
  • 11.2.14 KANEKA CORPORATION

12 ADJACENT & RELATED MARKETS

• 12.1 INTRODUCTION
• 12.2 LIMITATIONS
• 12.3 CHROMATOGRAPHY REAGENTS MARKET
  • 12.3.1 MARKET DEFINITION
  • 12.3.2 MARKET OVERVIEW
• 12.4 CHROMATOGRAPHY REAGENTS MARKET, BY REGION
  • 12.4.1 NORTH AMERICA
  • 12.4.2 EUROPE
  • 12.4.3 ASIA PACIFIC
  • 12.4.4 LATIN AMERICA
  • 12.4.5 MIDDLE EAST & AFRICA

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS